Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregorio D Chazenbalk

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of Clinical Medicine|October 14, 2023
An Evolutionary Model for the Ancient Origins of Polycystic Ovary SyndromeDaniel A Dumesic, David H Abbott, Gregorio D Chazenbalk
Clinical and Translational Medicine|June 19, 2014
Pluripotent muse cells derived from human adipose tissue: a new perspective on regenerative medicine and cell therapyAriel A Simerman, Daniel A Dumesic, Gregorio D Chazenbalk
Thyroid : Official Journal of the American Thyroid Association|December 14, 2004
Evidence that the thyrotropin receptor protease is membrane-associated and is not within lipid raftsFrancesco Latrofa, Gregorio D Chazenbalk, Sandra M McLachlan, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2004
Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N terminus of the thyrotropin receptor A-subunitGregorio D Chazenbalk, Francesco Latrofa, Sandra M McLachlan, et al.
Current Opinion in Endocrine and Metabolic Research|May 5, 2020
Endocrine-Metabolic Dysfunction in Polycystic Ovary Syndrome: an Evolutionary PerspectiveDaniel A Dumesic, David H Abbott, Smriti Sanchita, et al.
Endocrinology|August 23, 2003
Evidence that the C terminus of the A subunit suppresses thyrotropin receptor constitutive activityChun-Rong Chen, Gregorio D Chazenbalk, Sandra M McLachlan, et al.
Endocrinology|September 10, 2003
Does thyrotropin cleave its cognate receptor?Gregorio D Chazenbalk, Chun-Rong Chen, Sandra M McLachlan, et al.
Endocrinology|March 18, 2003
Targeted restoration of cleavage in a noncleaving thyrotropin receptor demonstrates that cleavage is insufficient to enhance ligand-independent activityChun-Rong Chen, Gregorio D Chazenbalk, Sandra M McLachlan, et al.
Reproductive Biology and Endocrinology : RB&E|January 11, 2022
Polycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptationDaniel A Dumesic, Vasantha Padmanabhan, Gregorio D Chazenbalk, et al.
Obstetrical & Gynecological Survey|July 26, 2019
Polycystic Ovary Syndrome: Impact of Lipotoxicity on Metabolic and Reproductive HealthKathleen M Brennan, Lindsay L Kroener, Gregorio D Chazenbalk, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Clinical Medicine|October 14, 2023
An Evolutionary Model for the Ancient Origins of Polycystic Ovary SyndromeDaniel A Dumesic, David H Abbott, Gregorio D Chazenbalk
Clinical and Translational Medicine|June 19, 2014
Pluripotent muse cells derived from human adipose tissue: a new perspective on regenerative medicine and cell therapyAriel A Simerman, Daniel A Dumesic, Gregorio D Chazenbalk
Thyroid : Official Journal of the American Thyroid Association|December 14, 2004
Evidence that the thyrotropin receptor protease is membrane-associated and is not within lipid raftsFrancesco Latrofa, Gregorio D Chazenbalk, Sandra M McLachlan, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2004
Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N terminus of the thyrotropin receptor A-subunitGregorio D Chazenbalk, Francesco Latrofa, Sandra M McLachlan, et al.
Current Opinion in Endocrine and Metabolic Research|May 5, 2020
Endocrine-Metabolic Dysfunction in Polycystic Ovary Syndrome: an Evolutionary PerspectiveDaniel A Dumesic, David H Abbott, Smriti Sanchita, et al.
Endocrinology|August 23, 2003
Evidence that the C terminus of the A subunit suppresses thyrotropin receptor constitutive activityChun-Rong Chen, Gregorio D Chazenbalk, Sandra M McLachlan, et al.
Endocrinology|September 10, 2003
Does thyrotropin cleave its cognate receptor?Gregorio D Chazenbalk, Chun-Rong Chen, Sandra M McLachlan, et al.
Endocrinology|March 18, 2003
Targeted restoration of cleavage in a noncleaving thyrotropin receptor demonstrates that cleavage is insufficient to enhance ligand-independent activityChun-Rong Chen, Gregorio D Chazenbalk, Sandra M McLachlan, et al.
Reproductive Biology and Endocrinology : RB&E|January 11, 2022
Polycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptationDaniel A Dumesic, Vasantha Padmanabhan, Gregorio D Chazenbalk, et al.
Obstetrical & Gynecological Survey|July 26, 2019
Polycystic Ovary Syndrome: Impact of Lipotoxicity on Metabolic and Reproductive HealthKathleen M Brennan, Lindsay L Kroener, Gregorio D Chazenbalk, et al.
Pageof 4